4.6 Article

DW4TR: A Data Warehouse for Translational Research

期刊

JOURNAL OF BIOMEDICAL INFORMATICS
卷 44, 期 6, 页码 1004-1019

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jbi.2011.08.003

关键词

Data Warehouse; Translational research; Patient-centric data model; User interface; Ontology

资金

  1. Clinical Breast Care Project
  2. Gynecological Disease Program
  3. US Department of Defense through Henry Jackson Foundation for the Advancement of Military Medicine, Rockville, MD

向作者/读者索取更多资源

The linkage between the clinical and laboratory research domains is a key issue in translational research. Integration of clinicopathologic data alone is a major task given the number of data elements involved. For a translational research environment, it is critical to make these data usable at the point-of-need. Individual systems have been developed to meet the needs of particular projects though the need for a generalizable system has been recognized. Increased use of Electronic Medical Record data in translational research will demand generalizing the system for integrating clinical data to support the study of a broad range of human diseases. To ultimately satisfy these needs, we have developed a system to support multiple translational research projects. This system, the Data Warehouse for Translational Research (DW4TR), is based on a light-weight, patient-centric modularly-structured clinical data model and a specimen-centric molecular data model. The temporal relationships of the data are also part of the model. The data are accessed through an interface composed of an Aggregated Biomedical-Information Browser (ABB) and an Individual Subject Information Viewer (ISIV) which target general users. The system was developed to support a breast cancer translational research program and has been extended to support a gynecological disease program. Further extensions of the DW4TR are underway. We believe that the DW4TR will play an important role in translational research across multiple disease types. (C) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Advancing nonclinical innovation and safety in pharmaceutical testing

Elizabeth J. Baker, Nancy A. Beck, Ellen L. Berg, Helene D. Clayton-Jeter, P. Charukeshi Chandrasekera, J. Lowry Curley, Bruce A. Donzanti, Lorna C. Ewart, Jane M. Gunther, J. Gerry Kenna, Edward L. LeCluysell, Michael N. Liebman, Catherine L. Pugh, Paul B. Watkins, Kristie M. Sullivan

DRUG DISCOVERY TODAY (2019)

Article Oncology

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome

Cody Plasterer, Shirng-Wern Tsaih, Amy R. Peck, Inna Chervoneva, Caitlin O'Meara, Yunguang Sun, Angela Lemke, Dana Murphy, Jennifer Smith, Sophia Ran, Albert J. Kovatich, Jeffrey A. Hooke, Craig D. Shriver, Hai Hu, Edith P. Mitchell, Carmen Bergom, Amit Joshi, Paul Auer, Jeremy Prokop, Hallgeir Rui, Michael J. Flister

BREAST CANCER RESEARCH AND TREATMENT (2019)

Correction Immunology

The Immune Landscape of Cancer (vol 48, pg 812, 2018)

Vesteinn Thorsson, David L. Gibbs, Scott D. Brown, Denise Wolf, Dante S. Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F. Gao, Christopher L. Plaisier, James A. Eddy, Elad Ziv, Aedin C. Culhane, Evan O. Paull, I. K. Ashok Sivakumar, Andrew J. Gentles, Raunaq Malhotra, Farshad Farshidfar, Antonio Colaprico, Joel S. Parker, Lisle E. Mose, Nam Sy Vo, Jianfang Liu, Yuexin Liu, Janet Rader, Varsha Dhankani, Sheila M. Reynolds, Reanne Bowlby, Andrea Califano, Andrew D. Cherniack, Dimitris Anastassiou, Davide Bedognetti, Younes Mokrab, Aaron M. Newman, Arvind Rao, Ken Chen, Alexander Krasnitz, Hai Hu, Tathiane M. Malta, Houtan Noushmehr, Chandra Sekhar Pedamallu, Susan Bullman, Akinyemi I. Ojesina, Andrew Lamb, Wanding Zhou, Hui Shen, Toni K. Choueiri, John N. Weinstein, Justin Guinney, Joel Saltz, Robert A. Holt, Charles S. Rabkin, Alexander J. Lazar, Jonathan S. Serody, Elizabeth G. Demicco, Mary L. Disis, Benjamin G. Vincent, Ilya Shmulevich

IMMUNITY (2019)

Editorial Material Pharmacology & Pharmacy

Translational Informatics Connects Real-World Information to Knowledge in an Increasingly Data-Driven World

Caitrin W. McDonough, Matthew K. Breitenstein, Mohamed Shahin, Philip E. Empey, Robert R. Freimuth, Lang Li, Michael Liebman, Sony Tuteja

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Article Oncology

Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers

Olena Odnokoz, Pengfei Yu, Amy R. Peck, Yunguang Sun, Albert J. Kovatich, Jeffrey A. Hooke, Hai Hu, Edith P. Mitchell, Hallgeir Rui, Serge Y. Fuchs

CANCER BIOLOGY & THERAPY (2020)

Article Oncology

Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer

Yi Zhang, Jianfang Liu, Praveen-Kumar Raj-Kumar, Lori A. Sturtz, Anupama Praveen-Kumar, Howard H. Yang, Maxwell P. Lee, J. Leigh Fantacone-Campbell, Jeffrey A. Hooke, Albert J. Kovatich, Craig D. Shriver, Hai Hu

BREAST CANCER RESEARCH AND TREATMENT (2020)

Article Environmental Sciences

Shifting the Paradigm: The Dress-COV Telegram Bot as a Tool for Participatory Medicine

Michela Franchini, Stefania Pieroni, Nicola Martini, Andrea Ripoli, Dante Chiappino, Francesca Denoth, Michael Norman Liebman, Sabrina Molinaro, Daniele Della Latta

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Oncology

Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer

Brenton A. Maisel, Misung Yi, Amy R. Peck, Yunguang Sun, Jeffrey A. Hooke, Albert J. Kovatich, Craig D. Shriver, Hai Hu, Marja T. Nevalainen, Takemi Tanaka, Nicole Simone, Li Lily Wang, Hallgeir Rui, Inna Chervoneva

Summary: The density and spatial relationship of CD163(+) TAMs in tumor tissue are associated with unfavorable prognosis in breast cancer.

CANCERS (2022)

Article Oncology

A Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection

Andrew Zhang, Hai Hu

Summary: Development of noninvasive diagnostic tests for early detection of multiple cancer types is crucial. A serum-based 4-microRNA diagnostic model showed superior performance in detecting 12 cancer types compared to existing sequencing-based tests. The simplicity of the model enables decentralized testing and wide adoption in the at-risk general population.

CANCERS (2022)

Meeting Abstract Oncology

Proteogenomics of laser microdissected difficult-to-treat breast cancers identifies Basal and Her2 patients associated with outcome differences.

Praveen-Kumar Raj-Kumar, Tao Liu, Lori A. Sturtz, Albert J. Kovatich, Marina A. Gritsenko, Vladislav A. Petyuk, Brenda Deyarmin, Jianfang Liu, Anupama Praveen-Kumar, Jason E. McDermott, Anil K. Shukla, Ronald J. Moore, Matthew E. Monroe, Bobbie-Jo M. Webb-Robertson, Jeffrey A. Hooke, Leigh Fantacone-Campbell, Leonid Kvecher, Jennifer Kane, Jennifer Melley, Stella Somiari, Stephen C. Benz, Justin Golovato, Shahrooz Rabizadeh, Patrick Soon-Shiong, Richard D. Smith, Richard J. Mural, Karin D. Rodland, Craig D. Shriver, Zhaoyu Li, Hai Hu

CANCER RESEARCH (2021)

Meeting Abstract Oncology

Multidimensional metabolomic stratification of ER+/HER2-compared to ER-/HER2-breast tumors.

Valerie Bussberg, Vladimir Tolstikov, Guisong Wang, Punit Shah, Rick Searfoss, Leigh Fantacone-Campbell, Jeffrey A. Hooke, Brenda Deyarmin, Rebecca N. Zingmark, Stella Somiari, Jianfang Liu, Leonid Kvecher, Bradley Mostoller, Lori Sturtz, Praveen-Kumar Raj-Kumar, Elder Granger, Linda Vahdat, Mary L. Cutler, Chas Bountra, Rangaprasad Sarangarajan, Hai Hu, Albert J. Kovatich, Michael A. Kiebish, Niven R. Narain, Craig D. Shriver

CANCER RESEARCH (2021)

Article Biochemical Research Methods

Comparative analysis of differentially abundant proteins quantified by LC-MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples

Lori A. Sturtz, Guisong Wang, Punit Shah, Richard Searfoss, Praveen-Kumar Raj-Kumar, Jeffrey A. Hooke, J. Leigh Fantacone-Campbell, Brenda Deyarmin, Mary Lou Cutler, Rangaprasad Sarangarajan, Niven R. Narain, Hai Hu, Michael A. Kiebish, Albert J. Kovatich, Craig D. Shriver

CLINICAL PROTEOMICS (2020)

Meeting Abstract Oncology

Breast cancer treatment and association with clinicopathologic features in TCGA

Jianfang Liu, J. Leigh Fantacone-Campbell, Albert J. Kovatich, Brenda Deyarmin, Bradley J. Mostoller, Jeffrey A. Hooke, Hallgeir Rui, Craig D. Shriver, Hai Hu

CANCER RESEARCH (2020)

Meeting Abstract Oncology

Evaluation of laser microdissected primary breast tumors for RNA Seq over bulk processing and validated with cohort control

Praveen-Kumar Raj-Kumar, Lori A. Sturtz, Albert J. Kovatich, Brenda Deyarmin, Jeffrey A. Hooke, Leigh Fantacone-Campbell, Anupama Praveen-Kumar, Jianfang Liu, James Craig, Leonid Kvecher, Jennifer Kane, Jennifer Melley, Stella Somiari, Stephen C. Benz, Justin Golovato, Shahrooz Rabizadeh, Patrick Soon-Shiong, Richard Mural, Craig D. Shriver, Hai Hu

CANCER RESEARCH (2020)

暂无数据